American International Group, Inc. Tenaya Therapeutics, Inc. Transaction History

American International Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.88 - $6.8 $567 - $1,339	-197 Reduced 0.85%	22,894 $119,000
Q4 2023 Feb 13, 2024	BUY	$1.73 - $3.39 $429 - $840	248 Added 1.09%	23,091 $74,000
Q3 2023 Nov 13, 2023	BUY	$2.55 - $5.65 $2,070 - $4,587	812 Added 3.69%	22,843 $58,000
Q2 2023 Aug 04, 2023	BUY	$2.64 - $7.64 $2,993 - $8,663	1,134 Added 5.43%	22,031 $129,000
Q1 2023 May 12, 2023	BUY	$1.92 - $3.59 $14,741 - $27,564	7,678 Added 58.08%	20,897 $59,000
Q4 2022 Feb 10, 2023	SELL	$1.68 - $3.19 $80 - $153	-48 Reduced 0.36%	13,219 $26,000
Q3 2022 Nov 14, 2022	BUY	$2.9 - $5.88 $542 - $1,099	187 Added 1.43%	13,267 $38,000
Q2 2022 Aug 12, 2022	SELL	$5.01 - $14.12 $5,586 - $15,743	-1,115 Reduced 7.85%	13,080 $74,000
Q1 2022 May 13, 2022	BUY	$9.41 - $19.3 $63,931 - $131,124	6,794 Added 91.8%	14,195 $167,000
Q4 2021 Feb 11, 2022	SELL	$18.41 - $29.58 $4,087 - $6,566	-222 Reduced 2.91%	7,401 $140,000
Q3 2021 Nov 12, 2021	BUY	$15.35 - $26.66 $117,013 - $203,229	7,623 New	7,623 $157,000

56.3M

900

400

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $91.8M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.